Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Reid Laurence
Relationship:   See Remarks, Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   18,103    

Indirect Shares

   1,766      
Direct Value   $2,721,062    

Indirect Value

   $265,447      
Total Shares   19,869      
Total Value   $2,986,509      


Alnylam Pharmaceuticals Inc $2,721,062 Alnylam Pharmaceuticals Inc $2,721,062
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alnylam Pharmaceuticals Inc ALNY SVP, Chief Business Of... 2014-12-31 18,103 2014-12-31 1,766    Premium*  
            Decibel Therapeutics, Inc. DBTX See Remarks, Director 2023-09-25 0 2021-09-15 0    Premium*  
* Premium Members only  

Records found :    24         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
DBTX Decibel Therapeutics, Inc... See Remarks   •       •      –    2023-09-25 4 D $0.00 $0 D/D (220,849) 0 0 -
DBTX Decibel Therapeutics, Inc... See Remarks   •       •      –    2023-03-16 4 A $0.00 $0 D/D 195,000 220,849 0 -
DBTX Decibel Therapeutics, Inc... President and Chief Executive   •       •      –    2021-09-15 4 B $7.64 $76,400 D/D 10,000 25,849 2.81 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-12-31 4 D $97.00 $271,794 D/D (2,802) 18,103 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-12-31 4 OE $15.99 $271,830 D/D 17,000 20,905 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-11-18 4 OE $7.10 $111,227 D/D 10,000 13,905 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-11-18 4 AS $90.30 $906,670 D/D (10,000) 3,905 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-08-18 4 AS $66.83 $909,030 D/D (13,500) 3,905 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-08-18 4 OE $7.10 $118,290 D/D 13,500 17,405 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-05-19 4 AS $57.07 $780,684 D/D (13,500) 3,905 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-05-19 4 OE $7.10 $118,290 D/D 13,500 17,405 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-02-19 4 AS $78.62 $1,633,240 D/D (20,400) 3,905 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-02-19 4 OE $7.10 $126,965 D/D 13,500 24,305 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2014-01-23 4 D $89.49 $330,934 D/D (3,698) 10,805 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2013-12-30 4 D $64.51 $59,994 D/D (930) 14,503 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2013-12-30 4 OE $15.99 $59,994 D/D 3,752 15,433 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2013-11-13 4 AS $53.36 $720,302 D/D (13,500) 11,681 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2013-11-13 4 OE $15.99 $215,865 D/D 13,500 25,181 0 -
ALNY Alnylam Pharmaceuticals I... SVP and Chief Business Officer   •       –      –    2013-05-28 4 OE $7.10 $35,500 D/D 5,000 16,681 0 -
ALNY Alnylam Pharmaceuticals I... SVP and Chief Business Officer   •       –      –    2013-05-28 4 AS $30.00 $150,000 D/D (5,000) 11,681 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2013-02-08 4 AS $25.00 $125,000 D/D (5,000) 11,681 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2013-02-08 4 OE $7.10 $35,500 D/D 5,000 16,681 0 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2012-02-21 4 B $10.75 $9,998 D/D 930 11,681 2.74 -
ALNY Alnylam Pharmaceuticals I... SVP, Chief Business Officer   •       –      –    2012-01-23 4 A $0.00 $0 D/D 10,751 10,751 0 -
  24  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us